ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea flag South Korea · Delayed Price · Currency is KRW
2,010.00
0.00 (0.00%)
At close: Jun 30, 2026

ENBIO Revenue

ENBIO had revenue of 14.14B KRW in the quarter ending March 31, 2026, with 2.24% growth. This brings the company's revenue in the last twelve months to 34.26B, up 1.15% year-over-year. In the year 2025, ENBIO had annual revenue of 33.95B, down -4.77%.

Revenue (ttm)
34.26B
Revenue Growth
+1.15%
P/S Ratio
0.64
Revenue / Employee
428.29M
Employees
80
Market Cap
21.84B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202533.95B-1.70B-4.77%
Dec 31, 202435.65B1.63B4.79%
Dec 31, 202334.02B-215.53M-0.63%
Dec 31, 202234.24B773.80M2.31%
Dec 31, 202133.47B-1.10B-3.17%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Humax388.31B
PC Direct384.72B
Moorim SP216.55B
Hurum96.85B
AUTO&57.35B
CU Medical Systems54.66B
Beauty Skin48.74B
Coloray International Investment44.55B
Revenue Rankings